Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Pluristem Therapeutics to Expand Manufacturing With New Facility

By Pharmaceutical Processing | July 26, 2011

Pluristem Therapeutics Inc., announced today that its wholly
owned Israeli subsidiary, Pluristem Ltd., has entered into an agreement with
MTM – Scientific Industries Center Haifa Ltd., for the leasing and construction
of a new state-of-the-art GMP manufacturing facility. The new facility will be
located near the company’s headquarters and existing facilities in MATAM Park,
Haifa, Israel and will support the manufacturing of Pluristem’s PLX (PLacental
eXpanded) cell product candidates for the treatment of critical limb ischemia
(CLI), intermittent claudication (IC), adjuvant hip replacement surgery, muscle
injuries, pulmonary hypertension (PH) and other diseases.

According to the agreement, the lease of the new facility
will commence as of January 2012 for a period of approximately 5 years with an
option to extend the lease for an additional 5 years.

Pluristem’s new regenerative medicine facility will be
cGMP/GTP compliant for clinical cell manufacturing and designed specifically to
meet both EMA and FDA regulatory requirements, as well as the standards
outlined by the Israeli Ministry of Health. Once constructed, the new facility
would have the capacity to produce PLX cells for the treatment of over 150,000
patients annually. As the company widens its clinical product candidate
portfolio and prepares to launch large-scale clinical trials in the U.S. and Europe,
the facility would enable Pluristem to meet increased manufacturing capacity
requirements. It would also enable Pluristem to meet marketing demands
following potential approval of its product candidates.

“Over the last few years, we have researched, developed
and fine-tuned the manufacturing methods, systems and techniques for the mass
production of clinical grade PLX products,” said Mr. Zami Aberman,
Pluristem’s Chairman & CEO. “The new manufacturing site will implement
our industry experience and support Pluristem’s strategy for potentially treating
millions of patients with life threatening diseases, positioning the company
for continued global collaborations and potential expansion of its partnerships
with pharmaceutical companies.”

 

 

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE